LAMPERT MARK N

CIK 00012338407 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001233840

Recent Transactions

50 trades

Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−568,019→ 686,974 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,458,838→ 4,172,298 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−568,019→ 686,974 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−568,019→ 686,974 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,458,838→ 4,172,298 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,821,663→ 5,663,912 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−568,019→ 686,974 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,821,663→ 5,663,912 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,458,838→ 4,172,298 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,458,838→ 4,172,298 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,821,663→ 5,663,912 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,458,838→ 4,172,298 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−568,019→ 686,974 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,821,663→ 5,663,912 total
Sale
INFINITY PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
2021-01-22$4.14/sh−2,821,663→ 5,663,912 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+1,150→ 1,230,038 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+2,850→ 3,183,600 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+700→ 828,000 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+1,150→ 1,230,038 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+1,150→ 1,230,038 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+2,850→ 3,183,600 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+700→ 828,000 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+1,150→ 1,230,038 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+2,850→ 3,183,600 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+700→ 828,000 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+1,150→ 1,230,038 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+700→ 828,000 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+2,850→ 3,183,600 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+700→ 828,000 total
Purchase
Capstone Holding Corp.$CAPS
Common Stock
2011-06-30$0.25/sh+2,850→ 3,183,600 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-31$2.70/sh−1,000→ 5,239,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-31$2.70/sh−1,000→ 5,239,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-31$2.70/sh−1,000→ 5,239,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-31$2.70/sh−1,000→ 5,239,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−25,000→ 5,319,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−61,000→ 5,240,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−18,000→ 5,301,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−25,000→ 5,319,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−25,000→ 5,319,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−18,000→ 5,301,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−61,000→ 5,240,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−18,000→ 5,301,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−61,000→ 5,240,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−18,000→ 5,301,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−61,000→ 5,240,447 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2010-03-30$2.70/sh−25,000→ 5,319,447 total
Sale
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2009-07-30$1.85/sh−9,000→ 5,890,457 total
Sale
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2009-07-30$1.85/sh−3,600→ 5,902,457 total
Sale
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2009-07-30$1.85/sh−3,000→ 5,899,457 total
Sale
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2009-07-30$1.85/sh−3,000→ 5,899,457 total

Companies

Recent Filings

Address

44 MONTGOMERY STREET 40TH FLOOR

SAN FRANCISCO, CA, 94104

View on SEC.gov